(Q45330911)

13 December 2017

title

Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologies (English)

1 reference

13 December 2017

2

1 reference

13 December 2017

Argyro Voumvouraki

1

1 reference

13 December 2017

Mairi Koulentaki

3

1 reference

13 December 2017

Maria Georgiadou

4

1 reference

13 December 2017

Stefanos Klironomos

5

1 reference

13 December 2017

Elias Kouroumalis

6

1 reference

13 December 2017

publication date

4 February 2012

1 reference

European Journal of Clinical Investigation

13 December 2017

published in

1 reference

13 December 2017

volume

42

1 reference

13 December 2017

issue

8

1 reference

13 December 2017

page(s)

815-822

1 reference

The activin axis in liver biology and disease.

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Latent TGF-beta binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Roles of activin in tissue repair, fibrosis, and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Activin receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

A complex role of activin A in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Activins and inhibins in endocrine and other tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Expression of activins C and E induces apoptosis in human and rat hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Induction of apoptosis in the murine liver with recombinant human activin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Intravenous administration of follistatin: delivery to the liver and effect on liver regeneration after partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Deregulation of the activin/follistatin system in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Smad7 is induced by norepinephrine and protects rat hepatocytes from activin A-induced growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

Influence of age and sex on serum concentrations of total dimeric activin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2012.02647.X

10.1111/J.1365-2362.2012.02647.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference